chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received the vaccine at the pharmacy, waited around in the parking lot  for 10-15 minutes (did not follow advise of remaining on site for direct observation); then drove off to go home. While driving he had an suspension that something was going to happen, and managed to pull into a random parking lot. Suddently/quickly he passed out (without putting  his car into park) and moment later (about 5 minutes), he regained consciousness hunched in the front seat of his truck and he truck up against a curb. He also claimed that he loss control of his bladder. Patient called his parents THEN the pharmacy immediately in which he was advised to calll 911 or seek medical attention. Patient made it home around 830pm safey and say he was really tired and was going to eat dinner to see how he feels. Patient still feels disoriented and does not want to seek medical attention at this time as of 840pm.
Pain, Redness and swelling towards the back Of the arm.  Don?t know if they put vaccine at that spot but it hurts there especially to touch
one rash was itchy; rashes were big and blotchy and elongated with "white things (pus) in the middle; rash on his arms and chest; fatigue; his arm also hurt and was sore; dizziness / lightheadedness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness / lightheadedness), FATIGUE (fatigue), VACCINATION SITE PAIN (his arm also hurt and was sore), RASH (rash on his arms and chest) and RASH PRURITIC (one rash was itchy) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Idiopathic pulmonary fibrosis.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced DIZZINESS (dizziness / lightheadedness), FATIGUE (fatigue) and VACCINATION SITE PAIN (his arm also hurt and was sore). On 10-Jan-2021, the patient experienced RASH (rash on his arms and chest), RASH PRURITIC (one rash was itchy) and RASH PUSTULAR (rashes were big and blotchy and elongated with "white things (pus) in the middle). On 09-Jan-2021, DIZZINESS (dizziness / lightheadedness), FATIGUE (fatigue) and VACCINATION SITE PAIN (his arm also hurt and was sore) had resolved. At the time of the report, RASH (rash on his arms and chest), RASH PRURITIC (one rash was itchy) and RASH PUSTULAR (rashes were big and blotchy and elongated with "white things (pus) in the middle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Body aches, lymphadenopathy, fatigue, subjective fever, diarrhea,  from 24 to 48 hours post injection.  Mild positional chest discomfort starting several days after injection, with feeling of chest fullness after exercise lasting approximately 2-3 weeks  Patient is a medical student and did not seek medical care.  Took ibuprofen for symptomatic relief
up all night; head is warm; I ache so bad/it hurts; cough; congestion/congested; pretty fatigued; body aches go down my body and muscles/Where I am sore I can push on it and it intensifies; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (up all night), FEELING HOT (head is warm), PAIN (I ache so bad/it hurts), COUGH (cough) and NASAL CONGESTION (congestion/congested) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B, 040821A and 006821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021, the patient experienced INSOMNIA (up all night), FEELING HOT (head is warm), PAIN (I ache so bad/it hurts), COUGH (cough), NASAL CONGESTION (congestion/congested), FATIGUE (pretty fatigued) and MYALGIA (body aches go down my body and muscles/Where I am sore I can push on it and it intensifies). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) for Cough and Congestion nasal, at an unspecified dose and frequency. At the time of the report, INSOMNIA (up all night), FEELING HOT (head is warm), PAIN (I ache so bad/it hurts), COUGH (cough), NASAL CONGESTION (congestion/congested), FATIGUE (pretty fatigued) and MYALGIA (body aches go down my body and muscles/Where I am sore I can push on it and it intensifies) outcome was unknown.            The patient had administered booster dose on 09-Dec-2021 . The patient  head was warm and the body aches go down the body and muscles.  Soreness intensified on pushing with pretty fatigued. When body aches, felt like thrash as hurt and gave a lot of ache. The patient stated that some side effect had relieved. The concomitant medication was not reported.   This case was linked to MOD-2021-408589, MOD-2021-408592 (Patient Link).
Varicella stored for possibly > 24 deg at 8 deg in freezer. Plan to revaccinate and draw titers.
This spontaneous report as received from a License Practical Nurse (L.P.N.) refers to a patient of unknown age and gender. In 29-JUL-2012 the patient received the first dose of GARDASIL (Lot #, dose and route not reported) and in July 2013 received the second dose of GARDASIL (Lot #, dose and route not reported). Concomitant therapy was not reported. No adverse effect reported. Additional information has been requested.
A non-serious report of expired FLUMIST administered was received from a physician concerning an adult patient. Neither medical history nor concomitant medications have been reported. On 01-Nov-2008 and 02-Nov-2008, seventy military personnel, including this patient received expired FLUMIST vaccine. The vaccine had an expiration date of March 2008. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding products from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 09-Apr-2009: Product Complaint Investigation results.
Pain near injection site.  Local 4cm surrounding warmth erythema to injection site R arm Hep A.  Infraclavicular lymphadenopathy.  Nausea, diarrhea.  Fevers/chills.  Headache.  All symptom onset within 24 hours.
About 2 weeks post-immunization, I developed severe dermatographia. My skin becomes red and inflamed at the slightest scratch or rub. Even wearing tight clothing triggers a flare. It has impacted my entire body, but is worst on my arms, neck, and back, particularly my left shoulder. These areas develop the largest and longest lasting welts. Additionally, my skin has been persistently itchy. All other environmental factors have been eliminated as possible causes (food, animals, plants, fabrics, skincare products, etc.)
From initial information received on 16Mar04 from a physician's office, regarding an adverse event occurring, it was reported that an 85 year old male pt received Fluzone SV 2003-2/4 USP, lot number U1131AA, administered IM in the left deltoid on 10Nov03.The pt had no reaction at the time of vaccination. He visited his physician for a regular office visit on 31Dec03 and had no complaints. On 02Jan04, he was seen in the ER for bilateral leg and arm weakness. This was his second visit to the ER, but no details were provided regarding his first visit. He was admitted to the hospital on 02Jan04 and was diagnosed with Guillain Barre Syndrome. The pt's recovery status is unk. From additional information received on 28May04 from a physician, the pt's hospital records were provided. The pt was admitted to the hospital on 02Jan04 with a three to four day history of progressive arm and leg weakness to the point where he had to walk with a cane and felt like he could fall when he was ambulating. Vital signs were stable on admission. Upon initial exam, the pt appeared weak and had difficulty getting out of bed. He was unable to push himself into a sitting position using his arms. His lower extremities appeared to be areflexic. He had a slightly positive Babinski. Romberg testing was negative. Pronator drift testing was also negative. His gait was watched without ataxia. Cerebellar testing of the lower extremities was normal. The pt denied concurrent fever, shortness of breath, coughing, muscle fasciculations or numbness or tingling of the hands or feet. He also denied exposure to botulism. Reportedly, the pt had not had any tick bites or traveled recently. A CAT scan of the brain on 02Jan04 revealed chronic findings with no acute anomaly identified. The pt's recovery status was not reported.
A red and itchy rash appeared 6 days after my first  Moderna Covid 19 injection at the injection site. The rash was approximately 3 inches long and 1 1/2 inches wide. A small welt was also present. I applied a topical steroid ointment which relieved the itchiness. The rash resolved after 3 days.
fever w/secondary gen sz on 10AUG;stiffened, eyes rolled back, stopped breathing, shaking extremities;fever since vax 9AUG96;
This spontaneous report as received from a medical assistant refers to a 4-year-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 28-JAN-2016, the patient was vaccinated with an incorrectly stored dose of PROQUAD (therapy type: rHA, # L031601, an expiration date 18-FEB-2017, dose, dose number, anatomical location and route of administration were not provided). It was reported that the refrigerator was out of range. This is one of several reports received from the same reporter. Additional information is not expected as all the data was already obtained.
Unexpected menstrual cycle. My cycles are very regular, every 28-30 days, finishing a regular cycle just 6 days ago. Today, two days after my second Pfizer COVID-19 vaccine, my cycle started again.
Sudden sore throat, no fever; 10/27 2 degree fever; 10/28 no fever, but sore throat continues. Tylenol, ice pack on head, liquids. See doctor 10/30, first available appointment. Missed 5 days work.
My daughter was at school and entered her class and that is all she remembers. She fell flat on her face and had snoring respirations and then had a seizure that lasted 2 minutes. She was taken by EMS to the hospital. Lab work was done and they did not want to do a CAT scan due to the radiation. She was referred to a neurologist and I made an appointment for Monday. She was not herself over the weekend. Was seen by Neurologist on Monday morning. They did a stat EEG. MRI was done on 11/14/18. She saw the Dr. again on the 15th. All tests were negative. She is still not herself and does not want to go out for fear she will have another seizure.
Visual disturbance; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of VISUAL IMPAIRMENT (Visual disturbance) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VISUAL IMPAIRMENT (Visual disturbance). At the time of the report, VISUAL IMPAIRMENT (Visual disturbance) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Got shingles right after got the shot; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patients received Shingles vaccine. On an unknown date, several days after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that he had Shingles twice once he was 16 years old and when he was much older. The reporter stated that he not wants to receive shot because he knows people that received Shingles vaccine and right after they experienced Shingles. Additional supportive information: This case had been linked with US2022AMR132562 and US2022AMR132560 reported by same reporter or different patient. Follow-up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR132562:Same reporter US-GSK-US2022AMR132560:Same reporter
Pt presented to clinic with mom for physical.  I looked pt up in database prior to appointment to check if any vaccines were recommended.  HPV9 was due.   First dose was given on 10/02/2020.   After checking patient in, I obtained consent from mom to administer second dose of HPV 9 to pt. After obtaining orders from provider, I obtained vaccine from Accuvax.  I administered vaccine to pt.  Pt tolerated well, no adverse reaction noted.  When I went to chart vaccine, I discovered that LPN had already administered the second dose of HPV9 on 05/05/2021, but had not charted it in database, contributing to my med error.
A non-serious spontaneous report of inadvertently administered expired FLUMIST was received from a health professional concerning a 41-year-old female. Neither medical history nor concomitant medication was reported for this patient. The product expired on 02-Dec-2010. On 07-Dec-2010, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Information has been received from a medical assistant concerning a 9 week old female with no pertinent medical history or drug allergies who on 05-FEB-2008 was vaccinated PO with her first 2.0 ml dose of Rotateq (lot# 658386/1734U).  There was no concomitant medication.  On 09-FEB-2008 the patient experienced bloody stools and questionable apnea and was hospitalized.  Lab diagnostic studies included stool studies which were pending, a metabolic panel and a CBC which showed normal results.  The patient was not recovered at the time of this report.  There was no product quality complaint.  Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of heart attack in a female patient who received SHINGRIX for prophylaxis. On 21st March 2019, the patient received SHINGRIX. In March 2019, less than a week after receiving SHINGRIX, the patient experienced vertigo (serious criteria hospitalization) and dizziness (serious criteria hospitalization). On 26th March 2019, the patient experienced heart attack (serious criteria hospitalization and GSK medically significant). On 29th March 2019, the patient experienced stroke (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the heart attack and stroke were unknown and the outcome of the vertigo and dizziness were recovered/resolved. It was unknown if the reporter considered the heart attack, stroke, vertigo and dizziness to be related to SHINGRIX. Additional details were provided as follows: The reporter was the concerned patient. The age at vaccination was not reported. The patient experienced dizziness or vertigo and symptoms lasted 2 to 3 days afterwards. The patient was not completely certain of the dates, but thinks that was when the events occurred. On 31st March 2019, the patient was hospitalized and they had not been able to determine the cause of the heart attack and stroke. The patient went cardiologists just gave her medicines and devices when the patient tries to follow up with them. The reporter did not consent to follow up with physician and declined to provide address, however gave permission to follow up via phone. No further details were provided.
Pt felt nausea, dry mouth, and became sweaty. Pt says symptoms started within minutes after vaccine.
Patient stated flushing started right after shot yesterday. This lasted a couple of hours (at most) and then subsided. It started again today around 2:30 pm/3 pm and was still present when reported at 5 pm.  (She  also reports sleeping "really well" last night despite some arm pain.)
Flank pain, UTI like sx and kidney inflammation without lab or imaging evidence of infection stone or other pathology.
Patient received her vaccine on 4/20/09 am and began screaming at 4/23/09. She was seen in the ER after 2018 on 4/25/09, when abdominal x ray, un, and fluorescein eye eval were negative. I also examined her there. She fell asleep @ 0200 4/26, slept 9hr, and was much better. She'd been happier in the 48 hr immediately after vaccine then she'd ever been.
It started with small red spots on tummy and legs.  The next morning he had it even worse covering his face, neck, and rest of his body. The doctor recommended Benadryl.  His face is covered in red bumps that are so close together that his face looks swollen.  According to the doctors, I'm suppose to keep an eye on his temperature to see if it spikes further than a low grade temperature.
18 hrs post inject egg sized, warm tender,mass inject site in rt deltoid; no fever; tender in rt axilla; pneumovax given in lt arm w/o discomfort;
Information has been received from physician and a 74 year old male with Parkinsonism, hypertension and allergies to penicillin, iodine and erythromycin who on 25-JUL-2007 was vaccinated with Zostavax (Oka/Merck) in the left upper arm subcutaneously.  Concomitant therapy included lisinopril (manufacturer unknown), alprazolam (Xanax), carbidopa, entacapone (Comtan) tolterodine tartrate (Detrol LA) and zolpidem tartrate (Ambien) and Parkinson's medication (unspecified).  On 27-AUG-2007 the patient developed seven to eight isolated lesions on his bilateral upper and lower extremities (temp. 97.5).  The patient did not have a history of chicken pox and did not have recent exposure to chicken pox or herpes zoster.  He had three lesions on his arms, one on his leg, one on his forehead and the others scattered on his body.  The patient described the lesions to be a quarter of an inch in diameter and were very itchy.  The patient tried to use diphenhydramine hydrochloride (Benadryl).  On 04-SEP-2007, a specimen of a dry scab was sent to the laboratory.  They were all small scabs.  They soaked for approximately one week.  Sample #1 was taken from the right forearm; adequate specimen, no VZV identified, negative, (+) B-Globin.  Sample #2 taken from the right bicep scab; inadequate specimen, negative for B-Globin, no strand ID.  Sample #3 taken from the left posterior thigh scab; inadequate specimen, negative for B-Globin, no strand ID.  Photos were not taken of the patient's lesions.  As of 04-SEP-2007, the patient had not recovered.  Additional information is not expected.
Fever for 3 days Pain on Lt arm Swollen, rash and redness on left arm Body ache Headache Tingling on feet
This spontaneous report as received from a pharmacist via Pfizer, refers to an elderly patient of unknown age and gender. No medical history or concurrent conditions were provided. On an unknown date, several years ago, the patient was vaccinated with PNEUMOVAX23 (dose, route and lot number not provided). No co-suspect or concomitant therapies were reported. On an unspecified date, the patient experienced pneumonia. At the time of the report, the outcome of the event was recovering/resolving (reported as "recently getting over pneumonia"). The causality was not provided. Additional information is not expected because the reporter details were not provided.
Large lump- size of "grape" in arm - where shot administered for one week - then thereafter, remains a lump "pea" size in upper left arm.
Pancreatitis; The initial case was missing the following minimum criteria: unidentifiable patient. Upon receipt of follow-up information on 15Sep2022, this case now contains all required information to be considered valid.    A child patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PANCREATITIS (medically significant), outcome "unknown".  VAERS is a national passive vaccine safety surveillance system managed by CDC and FDA that monitors adverse events after vaccination. VAERS accepts reports of postvaccination adverse events from health care providers, vaccine manufacturers, and members of the public. Signs, symptoms, and diagnostic findings in VAERS reports are assigned Medical Dictionary for Regulatory Activities preferred terms (MedDRA PTs) by VAERS staff. Reports of serious events to VAERS were reviewed by CDC and FDA physicians to form a consensus clinical impression based on available data. VAERS reports were described by serious and nonserious status, demographic characteristics, and MedDRA PTs. VAERS is a passive reporting system and is subject to reporting biases and underreporting, especially of nonserious events.; Sender's Comments: Limited information precludes a comprehensive causality assessment, however based on the implied temporal association, the contributory role of suspect drug BNT162B2 cannot be excluded for the reported event pancreatitis. The detailed clinical course would be helpful for further assessment. The case can be reassessed based on the follow-up information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators as appropriate.,Linked Report(s) : US-PFIZER INC-202201169694 same article/drug, different patient/event;US-PFIZER INC-202201169689 same article/drug, different patient/event;US-PFIZER INC-202201169691 same article/drug, different patient/event;US-PFIZER INC-202201169690 same article/drug, different patient/event;US-PFIZER INC-202201169693 same article/drug, different patient/event;US-PFIZER INC-202201169695 same article/drug, different patient/event;
He developed fever shortly after the vaccine, with worsening heart failure and oxygen requirements. Infectious work-up so far negative, but still ongoing
Extreme (water-like) diahrrea, chills, nausea, dry-heeves, extremely sore right arm where shot was given. My shot was given on 4/16/2021 and these symptoms occured on the same day from 1p to 830p. I took a anti-diarrhea medicine. From 9p to about 4am (4/17/2021) I had nausea and extreme abdominal pain.